Cabot Corp Forecasted to Earn Q1 2020 Earnings of $0.76 Per Share (NYSE:CBT)

Cabot Corp (NYSE:CBT) – Northcoast Research issued their Q1 2020 earnings per share (EPS) estimates for shares of Cabot in a research report issued on Wednesday, November 6th. Northcoast Research analyst K. Hocevar anticipates that the specialty chemicals company will post earnings per share of $0.76 for the quarter. Northcoast Research has a “Buy” rating and a $45.00 price target on the stock. Northcoast Research also issued estimates for Cabot’s Q2 2020 earnings at $0.96 EPS, Q3 2020 earnings at $1.03 EPS, Q4 2020 earnings at $1.11 EPS and FY2021 earnings at $4.35 EPS.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $1.05 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.11 by ($0.06). The firm had revenue of $827.00 million during the quarter, compared to the consensus estimate of $849.44 million. Cabot had a net margin of 4.70% and a return on equity of 19.06%. The firm’s quarterly revenue was down 2.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.00 earnings per share.

Several other analysts have also weighed in on CBT. Loop Capital lowered Cabot from a “buy” rating to a “hold” rating and lowered their price objective for the company from $69.00 to $41.00 in a report on Monday, August 5th. TheStreet lowered Cabot from a “b-” rating to a “c+” rating in a report on Wednesday, August 14th. JPMorgan Chase & Co. lowered Cabot from an “overweight” rating to a “neutral” rating and boosted their price objective for the company from $40.00 to $45.00 in a report on Wednesday. They noted that the move was a valuation call. ValuEngine lowered Cabot from a “hold” rating to a “sell” rating in a report on Friday, November 1st. Finally, UBS Group started coverage on Cabot in a research note on Thursday, October 10th. They issued a “neutral” rating and a $45.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $44.67.

Cabot stock traded up $0.51 during midday trading on Friday, hitting $50.23. The stock had a trading volume of 433,529 shares, compared to its average volume of 359,349. The company has a current ratio of 2.02, a quick ratio of 1.27 and a debt-to-equity ratio of 0.90. The stock has a market cap of $2.89 billion, a P/E ratio of 12.85, a P/E/G ratio of 1.30 and a beta of 1.52. Cabot has a 12 month low of $37.11 and a 12 month high of $50.90. The business has a fifty day moving average price of $44.86 and a 200 day moving average price of $44.04.

A number of hedge funds have recently modified their holdings of the business. New York State Teachers Retirement System boosted its stake in Cabot by 0.3% in the third quarter. New York State Teachers Retirement System now owns 95,425 shares of the specialty chemicals company’s stock valued at $4,325,000 after acquiring an additional 300 shares during the period. Bbva USA Bancshares Inc. boosted its stake in Cabot by 5.4% in the second quarter. Bbva USA Bancshares Inc. now owns 6,375 shares of the specialty chemicals company’s stock valued at $304,000 after acquiring an additional 326 shares during the period. 1ST Source Bank boosted its stake in Cabot by 2.0% in the second quarter. 1ST Source Bank now owns 17,130 shares of the specialty chemicals company’s stock valued at $817,000 after acquiring an additional 330 shares during the period. BBVA USA Bancshares Inc. boosted its stake in Cabot by 5.4% in the third quarter. BBVA USA Bancshares Inc. now owns 6,720 shares of the specialty chemicals company’s stock valued at $304,000 after acquiring an additional 345 shares during the period. Finally, Zebra Capital Management LLC boosted its stake in Cabot by 4.4% in the second quarter. Zebra Capital Management LLC now owns 9,695 shares of the specialty chemicals company’s stock valued at $463,000 after acquiring an additional 409 shares during the period. Institutional investors own 86.10% of the company’s stock.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and compounds of carbon black and rubber.

Further Reading: What is the Fibonacci sequence?

Earnings History and Estimates for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply